Delivery Order SPE2DB22D1106-SPE2DB25FEHK5
- Not listed
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,675.40 and is a delivery order with a firm fixed price. It is for the supply of 4,567,909,459 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,416.39 and has a completion date of February 7, 2024. The contract is for the supply of 4,563,574,052 units of the medication Vyvanse 30 mg capsules in 100s. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,988.41, is a delivery order for 4,567,721,418 units of Vyvanse 30 mg capsules. The contract has a period of performance through March 28, 2025 and is a firm fixed-price contract. AmerisourceBergen is the prime contractor, and there is no set-aside designation for this award. The contract award...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,809.54 firm-fixed-price delivery order is for 4,556,517,806 units of the medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of March 10, 2022 and was awarded on March 9, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,679.50, is a delivery order for the supply of 4,567,055,954 units of the medication Vyvanse 50 mg capsules. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,085.15, is a Firm Fixed Price delivery order for the supply of 4,567,557,992 units of the prescription drug Vyvanse 30 mg capsules. The contract has an ultimate completion date of March 13, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,296.22 firm fixed-price delivery order is for the supply of 4,566,498,336 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of November 21, 2024 and was awarded on November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,745.42 Firm Fixed Price Delivery Order is for the supply of 4,566,151,169 units of the prescription medication Vyvanse 30 mg capsules. The award has an ultimate completion date of October 21, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,968.56 firm-fixed-price delivery order is for the supply of 4,567,025,816 units of the medication Vyvanse 60 mg capsules. The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,783.60 firm-fixed-price delivery order is for 4,567,860,309 units of the prescription medication Vyvanse 50 mg capsules. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEHK5Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $6,759.37. The award is for the supply of 4,567,887,842 units of the medication Vyvanse 30 mg capsules. The contract has an Ultimate Completion Date of April 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 4/11/25 |